We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$2.48B
Cap. Flow %
-27.43%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 3.09%
2 Consumer Discretionary 2.5%
3 Technology 1.62%
4 Financials 1.05%
5 Communication Services 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOLF icon
1326
PUT
Wolfspeed
WOLF
$1.23B
$82K ﹤0.01%
205,500
-635,700
-76% -$1.45M
TMC icon
1327
TMC The Metals Company
TMC
$1.54B
$79.2K ﹤0.01%
+12,000
New +$46K
MUR icon
1328
Murphy Oil
MUR
$5.7B
$78.8K ﹤0.01%
+3,500
New +$78K
TGB
1329
PUT
Trekor Metals
TGB
$2.48B
$78.8K ﹤0.01%
+25,000
New +$58.5K
VKTX icon
1330
PUT
Viking Therapeutics
VKTX
$3.7B
$74.2K ﹤0.01%
2,800
-37,200
-93% -$979K
ARRY icon
1331
PUT
Array Technologies
ARRY
$803M
$73.8K ﹤0.01%
12,500
-20,000
-62% -$121K
WOLF icon
1332
CALL
Wolfspeed
WOLF
$1.23B
$71.8K ﹤0.01%
+180,000
New +$410K
NKTR icon
1333
Nektar Therapeutics
NKTR
$2.39B
$71.7K ﹤0.01%
+2,776
New +$31.2K
AMTB icon
1334
Amerant Bancorp
AMTB
$1.16B
$70.2K ﹤0.01%
+3,852
New +$68.4K
SRTA
1335
Strata Critical Medical Inc
SRTA
$434M
$68.5K ﹤0.01%
+17,000
New +$55.3K
PETS icon
1336
PetMed Express
PETS
$41.7M
$65.1K ﹤0.01%
19,616
-38,138
-66% -$136K
HAFN icon
1337
Hafnia
HAFN
$3.84B
$64.9K ﹤0.01%
+13,000
New +$63.2K
VIR icon
1338
Vir Biotechnology
VIR
$1.46B
$63.5K ﹤0.01%
12,600
HUT
1339
PUT
Hut 8
HUT
$12.1B
$61.4K ﹤0.01%
3,300
CMA
1340
DELISTED
Comerica
CMA
$59.6K ﹤0.01%
1,000
-3,600
-78% -$201K
KURA icon
1341
CALL
Kura Oncology
KURA
$800M
$57.7K ﹤0.01%
+10,000
New +$61.3K
TGE.WS
1342
The Generation Essentials Group Warrants
TGE.WS
$56.1K ﹤0.01%
+140,127
New +$74.7K
FOLD
1343
DELISTED
Amicus Therapeutics
FOLD
$55.6K ﹤0.01%
9,700
-159,951
-94% -$1.03M
BORR
1344
CALL
Borr Drilling
BORR
$1.24B
$50.3K ﹤0.01%
27,500
ALDX icon
1345
Aldeyra Therapeutics
ALDX
$92.9M
$48.5K ﹤0.01%
12,664
-168,442
-93% -$435K
EXE
1346
Expand Energy Corp
EXE
$21.8B
$48.4K ﹤0.01%
+414
New +$46.2K
SPOK icon
1347
Spok Holdings
SPOK
$228M
$44.8K ﹤0.01%
+2,532
New +$40.8K
NUGT icon
1348
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$848M
$44.6K ﹤0.01%
+600
New +$41.7K
DAN icon
1349
PUT
Dana Inc
DAN
$2.9B
$42.9K ﹤0.01%
2,500
-101,500
-98% -$1.52M
FOA icon
1350
Finance of America Companies
FOA
$203M
$40.7K ﹤0.01%
+1,746
New +$36.7K

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.